To the full analysis
Covivio stock: growth
COV.PACovivio reported $1.18B in revenue for fiscal 2025, down 16.6% on the prior year, up 0.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.5%
per year from 2006 to 2025, per share −3.5%
Earnings (Annual rate)
1.3%
per year from 2006 to 2025, per share −5.6%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 0.6% | 0.5% | 3.5% |
| Revenue per share | −3.2% | −4.6% | −3.5% |
| Earnings | 15.5% | 4.4% | 1.3% |
| Earnings per share | 11.1% | −1.2% | −5.6% |
| Free cash flow | no data | −5.9% | no data |
| Free cash flow per share | no data | −10.7% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $611.53M | $638.45M | −$196.68M |
| 2007 | $998.66M | $1.37B | −$2.25B |
| 2008 | $1.21B | −$922.05M | $246.23M |
| 2009 | $1.1B | −$514.69M | $771.73M |
| 2010 | $832.24M | $965.64M | $299.84M |
| 2011 | $832.69M | $519.55M | $193.18M |
| 2012 | $844.44M | −$29.38M | −$275.2M |
| 2013 | $921.9M | $376.89M | $273.64M |
| 2014 | $1.1B | $104.73M | $225.11M |
| 2015 | $1.12B | $533.52M | $262.72M |
| 2016 | $1.07B | $867.39M | −$386.25M |
| 2017 | $1.11B | $1.01B | −$416.65M |
| 2018 | $1.4B | $830.6M | −$118.6M |
| 2019 | $1.41B | $827.74M | −$112.95M |
| 2020 | $1.15B | $398.66M | −$315.97M |
| 2021 | $1.18B | $1.02B | −$174.93M |
| 2022 | $1.33B | $687.79M | −$7.85M |
| 2023 | $1.13B | −$1.57B | $599.1M |
| 2024 | $1.41B | $75.46M | $4.26B |
| 2025 | $1.18B | $818.55M | $142.61M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 21 Aug 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.